These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36130635)

  • 1. Interventions in the diagnosis and adoption of pacemaker therapy in sinus node dysfunction patients: Results from the IMPROVE Brady study.
    Sethi R; Nesa Malik FT; Naik A; Afroz N; Reynolds DW; Kothari Y; Reddy V; Rajan V; Bergemann T; Dedrick A; Pandurangi UM; Khan KN; Narasimhan C
    Indian Heart J; 2022; 74(5):351-356. PubMed ID: 36130635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Under-utilization of pacemaker therapy for sinus node dysfunction - Real world data from South Asia.
    Narasimhan C; Sanyal J; Sethi R; Kothari Y; Malik FTN; Pandurangi U; Khan N; Sahu S; Lande J; Sachanandani H; Naik A
    Indian Heart J; 2017; 69(5):607-612. PubMed ID: 29054184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of falls and fractures after permanent pacemaker implantation in elderly patients with sinus node dysfunction.
    Brenner R; Ammann P; Yoon SI; Christen S; Hellermann J; Girod G; Knaus U; Duru F; Krasniqi N; Ramsay D; Sticherling C; Lippuner K; Kühne M
    Europace; 2017 Jul; 19(7):1220-1226. PubMed ID: 27702858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for reduced susceptibility to cardiac bradycardias in South Asians compared with Caucasians.
    Yuyun MF; Squire IB; Ng GA; Samani NJ
    Heart; 2018 Aug; 104(16):1350-1355. PubMed ID: 29463611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of AAIR versus DDDR pacing for patients with sinus node dysfunction: a long-term follow-up study.
    Mutagaywa RK; Tumaini B; Chin A
    Cardiovasc J Afr; 2021 Jan-Feb 23; 32(1):17-20. PubMed ID: 32946543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant.
    Akoum N; McGann C; Vergara G; Badger T; Ranjan R; Mahnkopf C; Kholmovski E; Macleod R; Marrouche N
    J Cardiovasc Electrophysiol; 2012 Jan; 23(1):44-50. PubMed ID: 21806700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the mental and physical components of the quality of life for patients six months after pacemaker implantation.
    Młynarski R; Włodyka A; Kargul W
    Cardiol J; 2009; 16(3):250-3. PubMed ID: 19437400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate control in patients with pacemaker affected by brady-tachy form of sick sinus syndrome.
    Boriani G; Padeletti L; Santini M; Gulizia M; Orazi S; Botto G; Capucci A; Biffi M; Martignani C; Ricci R; Vimercati M; DiStefano P; Grammatico A
    Am Heart J; 2007 Jul; 154(1):193-200. PubMed ID: 17584576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac pacing strategies and post-implantation risk of atrial fibrillation and heart failure events in sinus node dysfunction patients: a collaborative analysis of over 6000 patients.
    Chen S; Wang Z; Kiuchi MG; Andrea BR; Krucoff MW; Liu S; Pürerfellner H
    Clin Res Cardiol; 2016 Aug; 105(8):687-698. PubMed ID: 26913516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study.
    Chen S; Chen K; Tao Q; Zheng L; Shen F; Wu S; Fan J; Xu G; Wang L; Zhou X; Zhang S;
    Europace; 2014 Nov; 16(11):1595-602. PubMed ID: 24706091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized study of mode switching in a clinical trial of pacemaker therapy for sinus node dysfunction.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Glotzer TV; Silverman R; Yee R; Lee KL; Lamas GA;
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):153-60. PubMed ID: 15028043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Preventive" pacing in patients with tachy-brady syndrome (TBS): Confirming a common practice.
    Amir T; Ilan M; Fishman E; Michowitz Y; Khalameizer V; Katz A; Glikson M; Medina A; Rav Acha M
    Int J Clin Pract; 2020 Oct; 74(10):e13583. PubMed ID: 32533880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular block: impact on battery longevity-a sub-study of the ANSWER trial.
    Stockburger M; Defaye P; Boveda S; Stancak B; Lazarus A; Sipötz J; Nardi S; Rolando M; Moreno J
    Europace; 2016 May; 18(5):739-46. PubMed ID: 26612882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tachy-brady syndrome: Electrophysiology and evolving principles of management.
    Padda I; Sebastian SA; Khehra N; Mahtani A; Sethi Y; Panthangi V; Fulton M; Bandyopadhyay D; Johal G
    Dis Mon; 2024 Feb; 70(2):101637. PubMed ID: 37690863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate and long-term need for permanent cardiac pacing following aortic valve replacement.
    Viktorsson SA; Orrason AW; Vidisson KO; Gunnarsdottir AG; Johnsen A; Helgason D; Arnar DO; Geirsson A; Gudbjartsson T
    Scand Cardiovasc J; 2020 Jun; 54(3):186-191. PubMed ID: 31809597
    [No Abstract]   [Full Text] [Related]  

  • 16. The OPTI-MIND study: a prospective, observational study of pacemaker patients according to pacing modality and primary indications.
    Biffi M; Melissano D; Rossi P; Kaliska G; Havliĉek A; Pelargonio G; Romero R; Guastaferro C; Menichelli M; Vireca E; Frisoni J; Boriani G; Malacky T
    Europace; 2014 May; 16(5):689-97. PubMed ID: 24500787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pacemaker implantation and quality of life in the Mode Selection Trial (MOST).
    Fleischmann KE; Orav EJ; Lamas GA; Mangione CM; Schron E; Lee KL; Goldman L
    Heart Rhythm; 2006 Jun; 3(6):653-9. PubMed ID: 16731465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-loop stimulation as a physiological rate-modulated pacing approach based on intracardiac impedance to lower the atrial tachyarrhythmia burden in patients with sinus node dysfunction and atrial fibrillation.
    Ikeda S; Nogami A; Inoue K; Kowase S; Kurosaki K; Mukai Y; Tsutsui H
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1187-1194. PubMed ID: 32128918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial standstill in sinus node disease due to extensive atrial fibrosis: impact on dual chamber pacemaker implantation.
    Bellmann B; Roser M; Muntean B; Tscholl V; Nagel P; Schmid M; Schauerte P
    Europace; 2016 Feb; 18(2):238-45. PubMed ID: 25995399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimizing right ventricular pacing in patients with sinus node disease and prolonged PQ interval: The impact on exercise capacity.
    Krzyżanowski K; Michałkiewicz D; Orski Z; Wierzbowski R; Ryczek R; Cwetsch A
    Cardiol J; 2015; 22(1):75-9. PubMed ID: 24846513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.